Bespoke Extracts (BSPK) EBITDA (2011 - 2025)
Bespoke Extracts' (BSPK) quarterly EBITDA came in at -$53891.0 in Q3 2025, up 79.47% year-on-year from -$30028.3 in Q3 2024, and up 66.73% quarter-over-quarter from -$161958.0 in Q2 2025.
Bespoke Extracts (BSPK) EBITDA (2011 - 2025) Analysis & Trends
Bespoke Extracts has disclosed EBITDA across 15 years of filings, most recently posting -$53891.0 for Q3 2025.
- EBITDA for Q3 2025 came in at -$53891.0, up 79.47% year-over-year; the trailing twelve-month figure through Sep 2025 was -$640301.0 (up 40.74% YoY), and the FY2024 annual result was -$994628.0, up 32.43% from the prior year.
- EBITDA came in at -$53891.0 for Q3 2025 at Bespoke Extracts, up from -$161958.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of $3.0 million in Q3 2021 to a low of -$1.1 million in Q3 2022.
- The 5-year median for EBITDA is -$296192.0 (2023), against an average of -$245110.7.
- Peak annual rise in EBITDA reached 90.67% in 2021, while the deepest fall reached 4.19% in 2021.
- Bespoke Extracts' EBITDA stood at -$67933.0 in 2021, then plunged by 1226.57% to -$901176.0 in 2022, then soared by 70.6% to -$264914.0 in 2023, then jumped by 32.39% to -$179114.0 in 2024, then jumped by 69.91% to -$53891.0 in 2025.
- The last three EBITDA figures came in at -$53891.0 (Q3 2025), -$161958.0 (Q2 2025), and -$245338.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -98.81 Mn |
| 10 | Bespoke Extracts | - | - | 234,175.00 | -53,891.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -53,891.00 |
| Jun 30, 2025 | -161,958.00 |
| Mar 31, 2025 | -245,338.00 |
| Dec 31, 2024 | -179,114.00 |
| Sep 30, 2024 | -262,468.00 |
| Jun 30, 2024 | -250,243.00 |
| Mar 31, 2024 | -302,803.00 |
| Dec 31, 2023 | -264,914.00 |
| Sep 30, 2023 | -296,192.00 |
| Jun 30, 2023 | -467,502.00 |
| Mar 31, 2023 | -443,370.00 |
| Dec 31, 2022 | -901,176.00 |
| Sep 30, 2022 | -1.13 Mn |
| Jun 30, 2022 | -1.01 Mn |
| Mar 31, 2022 | -972,675.00 |
| Nov 30, 2021 | -67,933.00 |
| Aug 31, 2021 | 2.96 Mn |
| May 31, 2021 | -299,571.00 |
| Feb 28, 2021 | -304,171.00 |
| Nov 30, 2020 | -202,106.00 |